Clinical Trials Browser

Phase EARLY_PHASE1 × Has results × Triple Negative Breast Neoplasms × Clear all

NCT03197389 2021-05-19

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Phase EARLY_PHASE1 Completed

54 enrolled 9 charts

Breast Neoplasms, Triple Negative Breast Neoplasms